Skip to content
healthcare.dev

Exelon

NDC 66758-144, rivastigmine, patch, extended release, from Sandoz Inc.

Product NDC
66758-144
Status
Listed
Labeler
Sandoz Inc
Dosage form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022083
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66758-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVASTIGMINE13.3 mg/24h

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
66758-144-316675801443130 PATCH in 1 CARTON (66758-144-31) / 24 h in 1 PATCH (66758-144-58)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b6ed6d15-116d-4596-92ce-3414574d7ba0

Use it

Look up 66758-144 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66758-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66758-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.